{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T13:57:48Z","timestamp":1782309468704,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Thoracic endovascular aortic repair (TEVAR) is a well-established therapy for descending aortic aneurysms (DTA). There is a paucity of large series reporting the mid- and long-term outcomes from this era. The main aim of this study was to evaluate the outcomes of TEVAR with regards to the effect of aortic morphology and procedure-related variables on survival, reintervention and freedom from endoleaks.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this retrospective single center study, we evaluated the clinical outcomes among 158 consecutive patients with DTA than underwent TEVAR between 2006 and 2019 at our center.\u00a0The cohort included 51% patients with device landing zones proximal to the subclavian artery and 25.9% patients undergoing an emergent or urgent TEVAR. The primary\u00a0outcome was survival, and secondary outcomes were reintervention and occurrence of endoleaks.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Median follow-up was 33\u00a0months [IQR 12 to 70] while 50 patients (30.6%) had longer than 5-year follow-up. With a median patient age of 74\u00a0years, post-operative Kaplan Meyer survival estimates were 94.3% (95%CI 90.8\u201398.0, SE 0.018%) at 30\u00a0days, 76.4% (95%CI 70.0\u201383.3, SE 0.034%) at one year and, 52.9% (95%CI\u00a045.0\u201362.2, SE 0.043%) at five years. Freedom from reintervention at 30\u00a0days, one year, and five years\u00a0was 92.9% (95%CI 89.0\u201397.1, SE 0.021%), 80.0% (95%CI 72.6\u201388.1, SE 0.039%), and\u00a052.8% (95%CI 41.4\u201367.4, SE 0.065%), respectively. On cox regression analysis greater aneurysm diameter, and the use of\u00a0device landing zones in aortic regions 0\u20131 were associated with an increased probability of\u00a0all-cause mortality, and with reintervention during follow-up. Independent of aneurysm size undergoing urgent or emergent TEVAR was associated with higher mortality risk for the first three years post-operative but not on long-term follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Larger aneurysms and those requiring stent-graft landing in aortic zones 0 or 1, are associated with higher risk for mortality and reintervention. There remains a need to optimize clinical management and device design for larger proximal aneurysms.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13019-023-02285-3","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T08:02:31Z","timestamp":1687248151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Outcomes and survival following thoracic endovascular repair in patients with aortic aneurysms limited to the descending thoracic aorta"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3314-7725","authenticated-orcid":false,"given":"Katharina","family":"Fankhauser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8030-9283","authenticated-orcid":false,"given":"Isaac","family":"Wamala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Penkalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Heck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hammerschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkmar","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4574-4655","authenticated-orcid":false,"given":"Semih","family":"Buz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,20]]},"reference":[{"key":"2285_CR1","doi-asserted-by":"crossref","unstructured":"Erbel R, et al. ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(41):2873\u2013926.","DOI":"10.1093\/eurheartj\/ehu281"},{"issue":"1","key":"2285_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ejvs.2016.06.005","volume":"53","author":"V Riambau","year":"2017","unstructured":"Riambau V, et al. Editor\u2019s choice\u2014management of descending thoracic aorta diseases. Eur J Vasc Endovasc Surg. 2017;53(1):4\u201352.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"5","key":"2285_CR3","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.jvs.2007.09.062","volume":"47","author":"SR Walsh","year":"2008","unstructured":"Walsh SR, et al. Endovascular stenting versus open surgery for thoracic aortic disease: systematic review and meta-analysis of perioperative results. J Vasc Surg. 2008;47(5):1094\u20138.","journal-title":"J Vasc Surg"},{"issue":"10","key":"2285_CR4","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.jacc.2009.11.047","volume":"55","author":"D Cheng","year":"2010","unstructured":"Cheng D, et al. Endovascular aortic repair versus open surgical repair for descending thoracic aortic disease a systematic review and meta-analysis of comparative studies. J Am Coll Cardiol. 2010;55(10):986\u20131001.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2285_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/ABUT7744","volume":"26","author":"L Sharples","year":"2022","unstructured":"Sharples L, et al. Endovascular stent grafting and open surgical replacement for chronic thoracic aortic aneurysms: a systematic review and prospective cohort study. Health Technol Assess. 2022;26(6):1\u2013166.","journal-title":"Health Technol Assess"},{"issue":"1S","key":"2285_CR6","doi-asserted-by":"publisher","first-page":"55S","DOI":"10.1016\/j.jvs.2020.05.076","volume":"73","author":"GR Upchurch Jr","year":"2021","unstructured":"Upchurch GR Jr, et al. Society for Vascular Surgery clinical practice guidelines of thoracic endovascular aortic repair for descending thoracic aortic aneurysms. J Vasc Surg. 2021;73(1S):55S-83S.","journal-title":"J Vasc Surg"},{"issue":"3","key":"2285_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-043323","volume":"11","author":"A McCarthy","year":"2021","unstructured":"McCarthy A, et al. Systematic review of endovascular stent grafting versus open surgical repair for the elective treatment of arch\/descending thoracic aortic aneurysms. BMJ Open. 2021;11(3): e043323.","journal-title":"BMJ Open"},{"issue":"4","key":"2285_CR8","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.jvs.2016.03.451","volume":"64","author":"CP Ammar","year":"2016","unstructured":"Ammar CP, et al. Anatomic severity grading score for primary descending thoracic aneurysms predicts procedural difficulty and aortic-related reinterventions after thoracic endovascular aortic repair. J Vasc Surg. 2016;64(4):912-920 e1.","journal-title":"J Vasc Surg"},{"key":"2285_CR9","doi-asserted-by":"crossref","unstructured":"Ishimaru S. Endografting of the Aortic Arch. J Endovasc Ther. 2004;11:II62\u2013II71.","DOI":"10.1583\/04-1407.1"},{"key":"2285_CR10","doi-asserted-by":"crossref","unstructured":"de Wreede LC, Fiocco M, Putter H. mstate: an R package for the analysis of competing risks and multi-state models. J. Stat. Softw. 2011;38(7)","DOI":"10.18637\/jss.v038.i07"},{"issue":"2","key":"2285_CR11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jvs.2017.06.094","volume":"67","author":"DN Ranney","year":"2018","unstructured":"Ranney DN, et al. Long-term results of endovascular repair for descending thoracic aortic aneurysms. J Vasc Surg. 2018;67(2):363\u20138.","journal-title":"J Vasc Surg"},{"issue":"2","key":"2285_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1177\/1526602815626560","volume":"23","author":"F Biancari","year":"2016","unstructured":"Biancari F, et al. Endovascular treatment of degenerative aneurysms involving only the descending thoracic aorta: systematic review and meta-analysis. J Endovasc Ther. 2016;23(2):387\u201392.","journal-title":"J Endovasc Ther"},{"issue":"25","key":"2285_CR13","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1161\/CIRCULATIONAHA.110.965756","volume":"123","author":"WA Lee","year":"2011","unstructured":"Lee WA, et al. Late outcomes of a single-center experience of 400 consecutive thoracic endovascular aortic repairs. Circulation. 2011;123(25):2938\u201345.","journal-title":"Circulation"},{"issue":"2","key":"2285_CR14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jvs.2016.12.136","volume":"66","author":"MF Conrad","year":"2017","unstructured":"Conrad MF, et al. Results of the VALOR II trial of the medtronic valiant thoracic stent graft. J Vasc Surg. 2017;66(2):335\u201342.","journal-title":"J Vasc Surg"},{"issue":"6","key":"2285_CR15","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.ejvs.2018.10.029","volume":"57","author":"S Hammo","year":"2019","unstructured":"Hammo S, et al. Outcome after endovascular repair of ruptured descending thoracic aortic aneurysm: a national multicentre study. Eur J Vasc Endovasc Surg. 2019;57(6):788\u201394.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"3","key":"2285_CR16","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.jvs.2021.08.056","volume":"75","author":"IN Naazie","year":"2022","unstructured":"Naazie IN, Gupta JD, Azizzadeh A, Arbabi C, Zarkowsky D, Malas MB. Risk calculator predicts 30-day mortality after thoracic endovascular aortic repair for intact descending thoracic aortic aneurysms in the vascular quality initiative. J Vasc Surg. 2022;75(3):833-841 e1.","journal-title":"J Vasc Surg"},{"issue":"3","key":"2285_CR17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jvs.2010.04.059","volume":"52","author":"J Chung","year":"2010","unstructured":"Chung J, et al. Risk factors for late mortality after endovascular repair of the thoracic aorta. J Vasc Surg. 2010;52(3):549\u201355.","journal-title":"J Vasc Surg"},{"issue":"4","key":"2285_CR18","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3349\/ymj.2015.56.4.904","volume":"56","author":"HC Lee","year":"2015","unstructured":"Lee HC, et al. Endovascular repair versus open repair for isolated descending thoracic aortic aneurysm. Yonsei Med J. 2015;56(4):904\u201312.","journal-title":"Yonsei Med J"},{"issue":"5","key":"2285_CR19","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.jtcvs.2005.12.058","volume":"131","author":"JJ Appoo","year":"2006","unstructured":"Appoo JJ, et al. Thoracic aortic stent grafting: improving results with newer generation investigational devices. J Thorac Cardiovasc Surg. 2006;131(5):1087\u201394.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"25","key":"2285_CR20","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1161\/CIRCULATIONAHA.109.908871","volume":"121","author":"FH Jonker","year":"2010","unstructured":"Jonker FH, et al. Outcomes of endovascular repair of ruptured descending thoracic aortic aneurysms. Circulation. 2010;121(25):2718\u201323.","journal-title":"Circulation"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-023-02285-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-023-02285-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-023-02285-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T08:06:19Z","timestamp":1687248379000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-023-02285-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,20]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2285"],"URL":"https:\/\/doi.org\/10.1186\/s13019-023-02285-3","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,20]]},"assertion":[{"value":"6 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This single center retrospective study was reviewed and approved by the Charit\u00e9 Universit\u00e4tsmedizin ethics committee (Ethics approval number EA2\/103\/20).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent was waived given the retrospective nature of the study. One patient whose images were used as a clinical example in Fig.\u00a0, signed an explicit informed consent allowing the use of her images in this publication. Patients still alive at the time of follow-up were contacted and they agreed to provide updated information of their clinical status for purposes of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Prof. Volkmar Falk reports a financial relationship with Abbott GmbH, Medtronic GmbH, Boston Scientific Inc., Novartis Pharma, Berlin Heart GmbH, Biotronik Se & Co., Edwards Lifesciences, JOTEC GmbH, Zurich Heart, and ETH Zurich in relation to research and study funds, and fees for lectures and speeches. All other authors have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"194"}}